Molecular mechanisms of neuropathological changes in Alzheimer's disease: a review
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F67985904%3A_____%2F13%3A00425399" target="_blank" >RIV/67985904:_____/13:00425399 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216224:14310/13:00065652 RIV/61988987:17110/13:A14019VF
Výsledek na webu
<a href="http://dx.doi.org/10.5114/fn.2013.34190" target="_blank" >http://dx.doi.org/10.5114/fn.2013.34190</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5114/fn.2013.34190" target="_blank" >10.5114/fn.2013.34190</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Molecular mechanisms of neuropathological changes in Alzheimer's disease: a review
Popis výsledku v původním jazyce
More than 100 years after description of Alzheimer's disease (AD), two major pathological processes observed already by Alois Alzheimer, remain as the main explanation of the pathogenesis of Alzheimer's disease. Important molecular interactions leading to AD neuropathology were described in amyloid cascade and in tau protein function. No clinical trials with novel therapies based on amyloid cascade and tau protein hypotheses have been successful. The main aim of recent research is focused on the question what is primary mechanism leading to the molecular development of AD pathology Promising explanation of triggering mechanism can be seen in vascular pathology that have direct influence on the development of pathological processes typical for Alzheimerdisease. Novel insight into a number of cellular signaling mechanisms, as well as mitochondrial function in Alzheimer disease could also bring explanations of initial processes leading to the development of this pathology.
Název v anglickém jazyce
Molecular mechanisms of neuropathological changes in Alzheimer's disease: a review
Popis výsledku anglicky
More than 100 years after description of Alzheimer's disease (AD), two major pathological processes observed already by Alois Alzheimer, remain as the main explanation of the pathogenesis of Alzheimer's disease. Important molecular interactions leading to AD neuropathology were described in amyloid cascade and in tau protein function. No clinical trials with novel therapies based on amyloid cascade and tau protein hypotheses have been successful. The main aim of recent research is focused on the question what is primary mechanism leading to the molecular development of AD pathology Promising explanation of triggering mechanism can be seen in vascular pathology that have direct influence on the development of pathological processes typical for Alzheimerdisease. Novel insight into a number of cellular signaling mechanisms, as well as mitochondrial function in Alzheimer disease could also bring explanations of initial processes leading to the development of this pathology.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FH - Neurologie, neurochirurgie, neurovědy
OECD FORD obor
—
Návaznosti výsledku
Projekt
<a href="/cs/project/NT11152" target="_blank" >NT11152: Epidemiologie a genetika Alzheimerovy choroby</a><br>
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2013
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Folia Neuropathologica
ISSN
1641-4640
e-ISSN
—
Svazek periodika
51
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
PL - Polská republika
Počet stran výsledku
9
Strana od-do
1-9
Kód UT WoS článku
000317316400001
EID výsledku v databázi Scopus
—